Powered by
ANN ARBOR—Officials at Ann Arbor-based Esperion Therapeutics Inc. (Nasdaq: ESPR), a pharmaceutical startup developing a new class of cholesterol-lowering drugs, announced a $200 million funding agreement with an investor group …
LIVONIA—The Livonia personnel management software developer WorkForce Software announced an equity investment from affiliates of Menlo Park, Calif.-based Evergreen Coast Capital Corp.. the technology-focused private equity arm of Elliott Management …
ANN ARBOR—The New York City-based privately held company Atairos has made an investment of undisclosed extent in ProQuest, the Ann Arbor-based privately held information and content provider. ProQuest officials said …
HOLLAND–The New York City-based private equity firm Crestview Partners announced the sale of Holland-based JR Automation Technologies LLC for $1.425 billion in cash to Hitachi, Ltd. Established in 1980, JR …
DETROIT – StockX, the online consumer “stock market of things,” announced that it has closed a $6 million round of funding from several celebrity investors, including actor Mark Wahlberg, rappers …
GRAND RAPIDS — The Grand Rapids-based data center management software developer Blue Medora announced the close of an $8.6 million Series B funding round led by St. Louis-based Lewis & …
ANN ARBOR — RetroSense Therapeutics, a privately held, clinical-stage biopharmaceutical company, announced that it has secured $6 million in a Series B financing to further investigate the use of gene …
ANN ARBOR — The supply chain design software developer LLamasoft said Tuesday it had closed a $50 million Series B financing round with affiliates of Goldman, Sachs & Co. The …
ANN ARBOR — XanEdu, a provider of content customization and mobile delivery, today announced $8.1 million in funding from new and existing investors including Ann Arbor-based Plymouth Ventures and Detroit-based …
DETROIT — Compuware Corp. (Nasdaq: CPWR) Tuesday announced the final ratio of its distribution of the 31,384,920 shares it owns in Covisint Corp. (Nasdaq: COVS), scheduled to take place on …